Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2009, Article ID 596560, 8 pages
http://dx.doi.org/10.1155/2009/596560
Research Article

In Vivo Measurements of Tumor Metabolism and Growth after Administration of Enzastaurin Using Small Animal FDG Positron Emission Tomography

1Section of Pediatric Hematology & Oncology, Herman B Wells Center for Pediatric Research, Indiana University Simon Cancer Center, 1044 West Walnut Street R4 321, Indianapolis, IN 46202, USA
2Therapeutic Area Oncology, Lilly Research Laboratories, Indianapolis, IN 46285, USA
3Program Phase Statistics, Lilly Research Laboratories, Indianapolis, IN 46285, USA
4Oncology Discovery, Lilly Research Laboratories, Indianapolis, IN 46285, USA
5Department of Radiology, Indiana University Cancer Center, Indianapolis, IN 46202, USA

Received 21 July 2008; Accepted 13 March 2009

Academic Editor: Bruce Baguley

Copyright © 2009 Karen E. Pollok et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Gupta, P. M. Price, and E. O. Aboagye, “PET for in vivo pharmacokinetic and pharmacodynamic measurements,” European Journal of Cancer, vol. 38, no. 16, pp. 2094–2107, 2002. View at Publisher · View at Google Scholar
  2. J. F. Vansteenkiste, “PET scan in the staging of non-small cell lung cancer,” Lung Cancer, vol. 42, no. 2, supplement 1, pp. S27–S37, 2003. View at Publisher · View at Google Scholar
  3. M. E. Juweid, G. A. Wiseman, J. M. Vose et al., “Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography,” Journal of Clinical Oncology, vol. 23, no. 21, pp. 4652–4661, 2005. View at Publisher · View at Google Scholar · View at PubMed
  4. J. G. Rajendran, D. A. Mankoff, F. O'Sullivan et al., “Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging,” Clinical Cancer Research, vol. 10, no. 7, pp. 2245–2252, 2004. View at Publisher · View at Google Scholar
  5. G. Antoch, N. Saoudi, H. Kuehl et al., “Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET,” Journal of Clinical Oncology, vol. 22, no. 21, pp. 4357–4368, 2004. View at Publisher · View at Google Scholar · View at PubMed
  6. G. Antoch, F. M. Vogt, L. S. Freudenberg et al., “Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology,” Journal of the American Medical Association, vol. 290, no. 24, pp. 3199–3206, 2003. View at Publisher · View at Google Scholar · View at PubMed
  7. R. Sasaki, R. Komaki, H. Macapinlac et al., “[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 23, no. 6, pp. 1136–1143, 2005. View at Publisher · View at Google Scholar · View at PubMed
  8. R. G. Blasberg and J. G. Tjuvajev, “Molecular-genetic imaging: current and future perspectives,” The Journal of Clinical Investigation, vol. 111, no. 11, pp. 1620–1629, 2003. View at Google Scholar
  9. P. J. Parker and J. Murray-Rust, “PKC at a glance,” Journal of Cell Science, vol. 117, part 2, pp. 131–132, 2004. View at Publisher · View at Google Scholar · View at PubMed
  10. M. A. Shipp, K. N. Ross, P. Tamayo et al., “Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning,” Nature Medicine, vol. 8, no. 1, pp. 68–74, 2002. View at Publisher · View at Google Scholar · View at PubMed
  11. M. Acevedo-Duncan, R. Patel, S. Whelan, and E. Bicaku, “Human glioma PKC-ι and PKC-βII phosphorylate cyclin-dependent kinase activating kinase during the cell cycle,” Cell Proliferation, vol. 35, no. 1, pp. 23–36, 2002. View at Publisher · View at Google Scholar
  12. J. R. Graff, A. M. McNulty, K. R. Hanna et al., “The protein kinase Cβ-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts,” Cancer Research, vol. 65, no. 16, pp. 7462–7469, 2005. View at Publisher · View at Google Scholar · View at PubMed
  13. O. Alcantara, L. Obeid, Y. Hannun, P. Ponka, and D. H. Boldt, “Regulation of protein kinase C (PKC) expression by iron: effect of different iron compounds on PKC-β and PKC-α gene expression and role of the 5-flanking region of the PKC-β gene in the response to ferric transferrin,” Blood, vol. 84, no. 10, pp. 3510–3517, 1994. View at Google Scholar
  14. T. Frese, N. C. Rouze, C. A. Bouman, K. Sauer, and G. D. Hutchins, “Quantitative comparison of FBP, EM, and Bayesian reconstruction algorithms for the IndyPET scanner,” IEEE Transactions on Medical Imaging, vol. 22, no. 2, pp. 258–276, 2003. View at Publisher · View at Google Scholar · View at PubMed
  15. N. C. Rouze and G. D. Hutchins, “Design and characterization of IndyPET-II: a high-resolution, high-sensitivity dedicated research scanner,” IEEE Transactions on Nuclear Science, vol. 50, no. 5, part 2, pp. 1491–1497, 2003. View at Publisher · View at Google Scholar
  16. K. Hamacher, H. H. Coenen, and G. Stocklin, “Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution,” Journal of Nuclear Medicine, vol. 27, no. 2, pp. 235–238, 1986. View at Google Scholar
  17. M. Tian, H. Zhang, T. Higuchi, N. Oriuchi, T. Inoue, and K. Endo, “Effect of mitomycin C and vinblastine on FDG uptake of human nonsmall-cell lung cancer xenografts in nude mice,” Cancer Biotherapy and Radiopharmaceuticals, vol. 19, no. 5, pp. 601–605, 2004. View at Publisher · View at Google Scholar
  18. J. Leyton, J. R. Latigo, M. Perumal, H. Dhaliwal, Q. He, and E. O. Aboagye, “Early detection of tumor response to chemotherapy by 3-deoxy- 3-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo,” Cancer Research, vol. 65, no. 10, pp. 4202–4210, 2005. View at Publisher · View at Google Scholar · View at PubMed
  19. C. Cullinane, D. S. Dorow, M. Kansara et al., “An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development,” Cancer Research, vol. 65, no. 21, pp. 9633–9636, 2005. View at Publisher · View at Google Scholar · View at PubMed
  20. M. D. Seemann, “Human PET/CT scanners: feasibility for oncological in vivo imaging in mice,” European Journal of Medical Research, vol. 9, no. 10, pp. 468–472, 2004. View at Google Scholar
  21. M. Tatsumi, Y. Nakamoto, B. Traughber, L. T. Marshall, J.-F. Geschwind, and R. L. Wahl, “Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose,” Cancer Research, vol. 63, no. 19, pp. 6252–6257, 2003. View at Google Scholar
  22. A. Gallo, G. Ceolotto, P. Pinton et al., “Metformin prevents glucose-induced protein kinase C-β2 activation in human umbilical vein endothelial cells through an antioxidant mechanism,” Diabetes, vol. 54, no. 4, pp. 1123–1131, 2005. View at Publisher · View at Google Scholar
  23. T. Ishizuka, K. Kajita, Y. Natsume et al., “Protein kinase C (PKC) β modulates serine phosphorylation of insulin receptor substrate-1 (IRS-1)—effect of overexpression of PKCβ on insulin signal transduction,” Endocrine Research, vol. 30, no. 2, pp. 287–299, 2004. View at Publisher · View at Google Scholar
  24. A. Kouroedov, M. Eto, H. Joch, M. Volpe, T. F. Lüscher, and F. Cosentino, “Selective inhibition of protein kinase Cβ2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells,” Circulation, vol. 110, no. 1, pp. 91–96, 2004. View at Publisher · View at Google Scholar · View at PubMed
  25. M. Yamamoto, N. A. Patel, J. Taggart, R. Sridhar, and D. R. Cooper, “A shift from normal to high glucose levels stimulates cell proliferation in drug sensitive MCF-7 human breast cancer cells but not in multidrug resistant MCF-7/ADR cells which overproduce PKC-βII,” International Journal of Cancer, vol. 83, no. 1, pp. 98–106, 1999. View at Publisher · View at Google Scholar
  26. G. J. Kelloff, J. M. Hoffman, B. Johnson et al., “Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development,” Clinical Cancer Research, vol. 11, no. 8, pp. 2785–2808, 2005. View at Publisher · View at Google Scholar · View at PubMed
  27. K. D. Miller, M. Miller, S. Mehrotra et al., “A physiologic imaging pilot study of breast cancer treated with AZD2171,” Clinical Cancer Research, vol. 12, no. 1, pp. 281–288, 2006. View at Publisher · View at Google Scholar · View at PubMed